Submitted New Drug Application To Manufacture And Market Arct-154, Next Generation Mrna Vaccine Against Covid-19, In Japan
28/04/2023 09:02
April 28 (Reuters) - Meiji Holdings Co Ltd 2269.T :
* MEIJI HOLDINGS CO LTD: SUBMITTED NEW DRUG APPLICATION TO
MANUFACTURE AND MARKET ARCT-154, NEXT GENERATION MRNA VACCINE
AGAINST COVID-19, IN JAPAN
Source text for Eikon: ID:nTSpb87c7d
Further company coverage: 2269.T
(Reporting by Satoshi Sugiyama)
((Satoshi.Sugiyama@thomsonreuters.com;))